SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001178913-23-002970
Filing Date
2023-08-23
Accepted
2023-08-23 08:00:44
Documents
73
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A zk2330202.htm   iXBRL 20-F/A 2440034
2 CERTIFICATION PURSUANT TO exhibit_12-1.htm EX-12.1 9581
3 CERTIFICATION PURSUANT TO exhibit_12-2.htm EX-12.2 9226
4 CERTIFICATION PURSUANT TO exhibit_13-1.htm EX-13.1 5251
5 GRAPHIC cgen_img01.jpg GRAPHIC 11268
  Complete submission text file 0001178913-23-002970.txt   7636871

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cgen-20221231.xsd EX-101.SCH 50829
7 XBRL CALCULATION FILE cgen-20221231_cal.xml EX-101.CAL 44825
8 XBRL DEFINITION FILE cgen-20221231_def.xml EX-101.DEF 156309
9 XBRL LABEL FILE cgen-20221231_lab.xml EX-101.LAB 473134
10 XBRL PRESENTATION FILE cgen-20221231_pre.xml EX-101.PRE 279771
67 EXTRACTED XBRL INSTANCE DOCUMENT zk2330202_htm.xml XML 1064377
Mailing Address 26 HAROKMIM STREET BUILDING D HOLON L3 5885849
Business Address 26 HAROKMIM STREET BUILDING D HOLON L3 5885849 011-972-3-765-8585
COMPUGEN LTD (Filer) CIK: 0001119774 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 000-30902 | Film No.: 231195188
SIC: 2836 Biological Products, (No Diagnostic Substances)